HB3432, titled the Trump Derangement Syndrome Research Act of 2025, would direct the Director of the National Institutes of Health to conduct or support research on “Trump Derangement Syndrome” (TDS) through existing NIH authorities, including the National Institute of Mental Health and other relevant institutes and centers. The bill defines TDS as a behavioral or psychological phenomenon involving intense emotional or cognitive reactions to Donald J. Trump, his actions, or his public presence.
The legislation lays out research objectives that include identifying the earliest documented cases or “patient zero” of TDS, studying its long-term psychological, social, and behavioral effects, analyzing contributing factors such as media exposure, political polarization, and social dynamics, and exploring possible interventions or coping strategies. It also requires collaboration with other federal agencies, academic institutions, and relevant organizations, and mandates a report to Congress within two years of enactment and annually thereafter on research progress, findings, and recommendations.
The bill’s stated findings link TDS to media coverage, selective reporting, unverified claims, and broader political polarization, and it references the 2024 assassination attempts against Donald J. Trump as part of the context for why the phenomenon should be studied. As drafted, the bill would not create a new NIH program or new statutory framework, but would require NIH to use existing programs and authorities to study the topic and report to Congress.
The general sentiment reflected in the bill text is strongly supportive of the need for research, but the framing is highly partisan and provocative, suggesting the measure is intended as a political statement as much as a research directive. Because no committee transcript or vote history is provided, there is no recorded legislative debate or bipartisan support to assess; the bill was simply referred to the House Committee on Energy and Commerce.
Potential points of contention include the legitimacy of “Trump Derangement Syndrome” as a medical or scientific concept, the bill’s overtly political framing, and whether NIH resources should be used for research on a term that many may view as satirical or non-clinical. Supporters would likely emphasize political polarization, media effects, and public health implications, while critics may object to the premise, terminology, and use of federal research agencies for a politically charged subject.
If enacted, the bill would direct NIH to study TDS using existing authorities, potentially influencing NIH research priorities within mental health and social-behavioral science. It would require annual reporting to Congress and could affect how federal researchers frame studies on political polarization, media influence, and psychologically driven responses to public figures, but it would not amend existing criminal, health, or education statutes beyond this research mandate.
There is no committee transcript or vote record showing formal debate, but the bill’s text signals a strongly partisan and satirical tone. The overall sentiment appears to be that of its sponsors advocating for research into a politically charged phenomenon, while the absence of legislative action beyond referral suggests the measure may be viewed skeptically or as controversial by others.
The main contention is whether “Trump Derangement Syndrome” is a valid subject for federal scientific research or a political slogan masquerading as one. Critics are likely to object to the bill’s premise, terminology, and references to media bias and assassination attempts, while supporters may argue that the bill addresses real issues of polarization, media influence, and public mental health. Another likely point of dispute is whether NIH should devote resources to this topic instead of more conventional biomedical or psychiatric research.